A composition according to claim 13 of Gray et al. U.S. 4,855,238.
7. Claim 70 of ‘451 and claim 64 of ‘022 are set forth below:
70. [Met-1, des-Cys1, des-Tyr2, des-Cys3]IFN-( polypeptide produced by a
DNA sequence coding therefore in a transformant organism, said product
having substantially the characteristics of human immune interferon.
64. The analog polypeptide of claim 63 that is [Met-1, des-Cys1, des-Tyr2,
des-Cys3]IFN-(.
8. Claim 13 of the ‘238 patent is set forth below:
13. A double stranded DNA according to claim 12 wherein the n amino acids are
9. When claim 13 of the ‘238 patent is read in view of the claims it depends upon
the polypeptide encoded by the DNA of the claim is [Met-1, des-Cys1, des-Tyr2,
des-Cys3]IFN-(.
Claim designations
10. The following claims are designated as corresponding to Count 2 (Paper 48 at
2-3):
Alton '022: 63 and 64
Alton '451: 70
Gray: 1-5 and 8-13.
5
Page: Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 Next
Last modified: November 3, 2007